Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
2.
Mol Psychiatry ; 21(4): 450-63, 2016 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-26878891

RESUMEN

The bed nucleus of the stria terminalis (BNST) is a center of integration for limbic information and valence monitoring. The BNST, sometimes referred to as the extended amygdala, is located in the basal forebrain and is a sexually dimorphic structure made up of between 12 and 18 sub-nuclei. These sub-nuclei are rich with distinct neuronal subpopulations of receptors, neurotransmitters, transporters and proteins. The BNST is important in a range of behaviors such as: the stress response, extended duration fear states and social behavior, all crucial determinants of dysfunction in human psychiatric diseases. Most research on stress and psychiatric diseases has focused on the amygdala, which regulates immediate responses to fear. However, the BNST, and not the amygdala, is the center of the psychogenic circuit from the hippocampus to the paraventricular nucleus. This circuit is important in the stimulation of the hypothalamic-pituitary-adrenal axis. Thus, the BNST has been largely overlooked with respect to its possible dysregulation in mood and anxiety disorders, social dysfunction and psychological trauma, all of which have clear gender disparities. In this review, we will look in-depth at the anatomy and projections of the BNST, and provide an overview of the current literature on the relevance of BNST dysregulation in psychiatric diseases.


Asunto(s)
Amígdala del Cerebelo/anatomía & histología , Trastornos Mentales/patología , Núcleos Septales/anatomía & histología , Amígdala del Cerebelo/patología , Animales , Hipocampo/metabolismo , Humanos , Sistema Hipotálamo-Hipofisario , Vías Nerviosas/metabolismo , Sistema Hipófiso-Suprarrenal , Reflejo de Sobresalto/fisiología , Núcleos Septales/metabolismo , Núcleos Septales/patología , Estrés Psicológico/fisiopatología
3.
Obstet Gynecol ; 93(3): 453-6, 1999 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-10074999

RESUMEN

Between 1986 and 1997, nine studies on health effects of oral contraceptives were published by the New England Journal of Medicine or JAMA. All of those studies showed no increased risk of breast cancer or protective effects against ovarian and endometrial cancer. Except for one study published in 1986, the major newspapers in the United States essentially ignored these findings, and The New York Times reported on other inconclusive studies that emphasized an oral contraceptive-breast cancer link.


Asunto(s)
Anticonceptivos Orales/efectos adversos , Medios de Comunicación de Masas , Neoplasias de la Mama/inducido químicamente , Neoplasias Endometriales/prevención & control , Femenino , Humanos , Neoplasias Ováricas/prevención & control , Factores de Riesgo , Estados Unidos , United States Food and Drug Administration
4.
Womens Health Issues ; 4(4): 196-208, 1994.
Artículo en Inglés | MEDLINE | ID: mdl-7849538

RESUMEN

PIP: Despite the fact that most Americans support the advertising of family planning methods, the minority opposition has influenced the formulation of contraceptive advertising policies. This article attempts to clarify the current status of contraceptive advertising and to suggest a sensible public policy for the future. Opening with a review of opinion polls taken since 1985, the article points out that 70% of station managers reported their belief that contraceptive advertising would offend many people despite the fact that 87% of respondents in a public survey indicated no objection to such advertising. The policies that network television stations have adopted are traced from those instituted in the 1960s by the National Association of Broadcaster's Code Authority. These policies govern the airing of Public Service Announcements (PSAs) as well as advertisements. Magazines and newspapers also resist accepting contraceptive advertising, although they do not face the same regulations as the broadcast media. US Food and Drug Administration policies also act as a barrier to product-specific advertisements on network television despite the fact that the American Medical Association no longer opposes such advertising and the American College of Obstetricians and Gynecologists offered to provide valid information about advertising claims to the media. A review of attempts to advertise contraceptives shows that opposition has dropped significantly in the past 10 years for advertisements in newspapers, on cable television, in magazines, on some commercial television stations, and on many radio stations. However, the major television networks still fail to accept such advertisements. Part of the change that is occurring can be attributable to the emergence of AIDS and the need to promote methods to prevent the disease. However, much AIDS-related advertising has been in the form of PSAs, which are less and less available. The major obstacles to contraceptive advertising today are media reluctance, government regulation, lack of consistent effort on the part of advertisers, and a lack of consensus in society about the importance of this issue. These limits are the symptoms of a society which has an unrealistic view of sexual activity. Therefore, contraceptive advertising alone will not change the US's high unintended pregnancy and abortion rates.^ieng


Asunto(s)
Publicidad , Dispositivos Anticonceptivos , Femenino , Humanos , Medios de Comunicación de Masas , Opinión Pública , Estados Unidos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...